Taiho Oncology to Showcase 14 Key Presentations at the ASH Annual Meeting in 2025 Taiho Oncology is set to present important findings at the 67th ASH Annual Meeting, showcasing 14 presentations, including six oral ones, focusing on hematologic cancers.

Taiho Oncology to Showcase 14 Key Presentations at the ASH Annual Meeting in 2025 #USA #Orlando #Taiho_Oncology #Hematologic_Cancers #ASH_2025

The Remarkable Growth of CAR T-Cell Therapy: Forecasts Reach $27.5 Billion by 2033 The CAR T-cell therapy market is expected to skyrocket from $2.7 billion in 2025 to over $27.5 billion by 2033, fueled by innovations and increasing adoption rates.

The Remarkable Growth of CAR T-Cell Therapy: Forecasts Reach $27.5 Billion by 2033 #United_States #Chicago #CAR_T-cell_Therapy #Immunotherapy_Innovations #Hematologic_Cancers